In the last 30 years, COPD has become more prevalent in American women, who now make up more than half of patients currently diagnosed—an estimated 7 million women, in all.
Initiatives across the country are expanding access to quality spirometry, a key component in the proper diagnosis and treatment of respiratory conditions like COPD and asthma.
GlaxoSmithKline and Theravance have completed enrollment of 16,000 patients for SUMMIT, a study to determine the impact of GSK’s Breo Ellipta on all cause mortality amongst patients with moderate COPD and cardiovascular disease.
Approximately $7.6 million has been invested in the network to promote cutting-edge research and foster collaboration between Canada’s top experts in asthma and COPD
Fifty years after the landmark 1964 US Surgeon General Report on Smoking and Health, smoking is deadlier than ever — now responsible for the deaths of 480,000 Americans each year.
The COPD Foundation (COPDF) is celebrating a decade of helping more than 24 million Americans living with COPD, through research, public health awareness, and educational materials for patients, caregivers, and medical professionals.
The cellular connectivity hub connects remote patients, providers, and other Alere products to a unified health platform.
Researchers have found the Surgeon General’s report of 1964, which first outlined the dangers of smoking and led to the development of tobacco control efforts, is responsible for adding nearly 20 years of life to eight million Americans.
A new ambulatory noninvasive ventilation device is proving effective at increasing exercise tolerance for patients with COPD, an important factor for improving patient outcomes and quality of life.
Electromed Inc has received FDA market clearance for its SmartVest SQL Airway Clearance System. SQL delivers high frequency chest wall oscillation (HFCWO) to promote airway clearance, improve bronchial drainage, and enhance mucus transport.